Overall, our data suggests that CXCL12 may preferentially activate survival signaling pathways rather than those involved in cell migration in CLL cells, although some of the pathway components (Gi, Erk, Akt) are common nodes. This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.